Wei Li

Company: Cytovia Therapeutics

Job title: Chief Scientific Officer

Seminars:

Optimizing the Differentiation of iPSC Therapies to Enable Large-Scale Manufacturing & Clinical Applications 10:30 am

Investigating the mechanisms by which differentiated Cytovia’s iNK cells exert their anti-tumor effects Demonstrating the complete maturation and potent anti-tumor activity of differentiated iNK cells for optimal efficacyRead more

day: Conference Day One

Industry Leaders’ Fireside Chat: Highlights & Hurdles from the Past Year 9:00 am

An interactive panel discussion from the industry leaders of the field to set the scene on the iPSC therapy space. Ask your questions live to understand the expert’s thoughts on key topics including: Highlighting and celebrating the big wins for iPSC community like recent start-ups and progress being made by US & Asian biopharma Considering…Read more

day: Conference Day One